Cargando…
Ataxia-telangiectasia: immunologic profile and clinical outcome
Autores principales: | De Lima Honório Dumas, Clarissa, Tavares, Fabiola Scancetti, De Paula Ramos Netto, Hermínio, Campos, Vanessa Silva Pereira, Valente, Cláudia França Cavalcante, Pereira, Luciana Lilian Dias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407111/ http://dx.doi.org/10.1186/1939-4551-8-S1-A203 |
Ejemplares similares
-
Transitional B cells and CD21low in patients with ataxia-telangiectasia
por: Bichuetti-Silva, Danielli Christinni, et al.
Publicado: (2015) -
Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015) -
One-year intravenous immunoglobulin replacement therapy: efficacy in reducing hospital admissions in pediatric patients with Inborn Errors of Immunity
por: Melo, Karina Mescouto de, et al.
Publicado: (2021) -
Immediate adverse events to intravenous immunoglobulin in pediatric patients with inborn errors of immunity: A longitudinal study with a pre-infusion protocol
por: Antunes, Thales Silva, et al.
Publicado: (2023) -
Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015)